Goldberg, Paul

Pridopidine for the Treatment of ALS—Results from the Phase 2 Healey ALS Platform Trial (S5.003)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000206526